Skip to main content
Clinical Trials/NCT02702297
NCT02702297
Completed
Not Applicable

Multimodales Monitoring Des Fetalen Inflammationsrisikos Bei frühem Vorzeitigen Blasensprung (PPROM)

Martin-Luther-Universität Halle-Wittenberg4 sites in 1 country57 target enrollmentJanuary 7, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Preterm Premature Rupture of Membranes
Sponsor
Martin-Luther-Universität Halle-Wittenberg
Enrollment
57
Locations
4
Primary Endpoint
Odds ratio for severe fetal/early onset neonatal Infection
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to examine whether the value of vaginal fluid cytokine levels as well as computerized fetal ECG analysis are suitable clinical parameters to detect an imminent intra-amniotic inflammation with a high risk of fetal inflammatory response syndrome (FIRS) or a neonatal early onset sepsis (EOS) and whether these parameters can be determined on a daily basis in the clinical monitoring of pregnancies complicated by PPROM.

Detailed Description

Preterm premature rupture of membranes (PPROM) is one of the leading causes for preterm birth and adverse neonatal outcome. Between 24 0/7 and 34 0/7 weeks of gestation the prolongation of pregnancy is the recommended course of action to reduce the risks of prematurity in most countries. An intra-amniotic infection resulting in fetal inflammatory response syndrome (FIRS) or early onset neonatal sepsis (EOS) is often associated with high morbidity and mortality. Standard monitoring includes the maternal response to inflammation (i.e. maternal serum parameters) as well as fetal signs of acute FIRS (i.e. fetal tachycardia, high cytokine level in amniotic fluid obtained by amniocentesis). Changes of fetal ECG-parameters are also a sign of an acute FIRS. Currently, there is no adequate parameter for the surveillance of a possible ongoing intra-amniotic infection. Other studies have reported a correlation between vaginal fluid interleukine 6 (IL6) collected noninvasively and the risk of FIRS and EOS. Information obtained by computerized fetal ECG analysis might be suitable to detect early signs of fetal infection before the manifestation of FIRS. With the implementation of a vaginal fluid collector it is possible to detect the vaginal fluid cytokine in clinical everyday routine. With the improvement of fetal ECG monitoring it is possible to record the fetal ECG daily. This study examines the correlation between these new parameters and the onset of fetal infection before the manifestation of a severe systemic fetal inflammation.

Registry
clinicaltrials.gov
Start Date
January 7, 2016
End Date
November 10, 2018
Last Updated
7 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Gregor Seliger

Dr. med.; chief resident

Martin-Luther-Universität Halle-Wittenberg

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of preterm rupture of the fetal membranes
  • Pregnancy between 24 0/7 and 34 0/7 weeks of gestation
  • Ability to give informed consent in german or english

Exclusion Criteria

  • Sign of acute amniotic infection syndrome
  • independent indication for urgent delivery
  • Active labor
  • Missing informed consent

Outcomes

Primary Outcomes

Odds ratio for severe fetal/early onset neonatal Infection

Time Frame: postpartum one point assessment/ first three days post partum

combined outcome - rate of: early onset neonatal sepsis, elevated IL6 concentration in cord blood sample, histological signs of funisitis

Secondary Outcomes

  • necrotizing enterocolitis(28 days)
  • Severe neonatal cerebral hemorrhage(28 days)
  • combined neonatal adverse outcome(28 days)
  • late onset neonatal sepsis(28 days)
  • umbilical cord blood IL 6 concentration(first day after delivery)
  • neonatal early onset sepsis(3 days)
  • histological funisitis(first day after delivery)

Study Sites (4)

Loading locations...

Similar Trials